Evidence map›Paper›PMID 24038683›Full record

ArticleApplied and environmental microbiology2013

Characteristics of cefotaxime-resistant Escherichia coli from wild birds in the Netherlands.

Kees Veldman, Peter van Tulden, Arie Kant, Joop Testerink, Dik Mevius

Open access · bronzeAbstract read
In one paragraph

Article in Applied and environmental microbiology, 2013. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 51 papers.

0numbers the graph read from it
0cells of the map it votes in
51citing papers in PubMed
1.8field-weighted citation impact, top 16% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

51 citing papers in PubMed, 84 citations in OpenAlex.

  1. Frequency and characterization of β-lactam-resistant Escherichia coli from wild birds from Marmara Region in Turkey.Brazilian journal of microbiology : [publication of the Brazilian Society for Microbiology] · 2026
    Article
  2. Review
  3. Article
  4. Prevalence and Antimicrobial Resistance ofAntibiotics (Basel, Switzerland) · 2025
    Review
  5. Article
  6. High Antimicrobial Susceptibility of Cloacal Enterococci andAntibiotics (Basel, Switzerland) · 2025
    Article
  7. Review
  8. Article
  9. Wild Birds as Drivers ofTransboundary and emerging diseases · 2024
    Article
  10. Multidrug-ResistantMicroorganisms · 2023
    Article
  11. High Frequency of Antibiotic Resistance Genes (ARGs) in the Lerma River Basin, Mexico.International journal of environmental research and public health · 2022
    Article
  12. Urban Pigeons (Antibiotics (Basel, Switzerland) · 2022
    Article
  13. Article
  14. Detection of blaMicrobial ecology · 2022
    Article
  15. TEM,CTX-M,SHV Genes in ESBL-ProducingAntibiotics (Basel, Switzerland) · 2022
    Article
  16. ESBL-ProducingAnimals : an open access journal from MDPI · 2022
    Article
  17. Article
  18. Article
  19. Article
  20. Prevalence and Characterization of ESBL/AmpC ProducingAntibiotics (Basel, Switzerland) · 2021
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 2 institutions in 1 country.

Kees VeldmanDepartment of Bacteriology and TSEs, Central Veterinary Institute of Wageningen UR, Lelystad, The Netherlands.
Peter van Tulden
Arie Kant
Joop Testerink
Dik Mevius
Wageningen University & Research · NLUtrecht University · NL

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Cloacal swabs from carcasses of Dutch wild birds obtained in 2010 and 2011 were selectively cultured on media with cefotaxime to screen for the presence of extended-spectrum β-lactamase (ESBL)/AmpC-producing Escherichia coli. Subsequently, all cefotaxime-resistant E. coli isolates were tested by broth microdilution and microarray. The presence of ESBL/AmpC and coexisting plasmid-mediated quinolone resistance (PMQR) genes was confirmed by PCR and sequencing. To determine the size of plasmids and the location of ESBL and PMQR genes, S1 pulsed-field gel electrophoresis (PFGE) was performed on transformants, followed by Southern blot hybridization. The study included 414 cloacal swabs originating from 55 different bird species. Cefotaxime-resistant E. coli isolates were identified in 65 birds (15.7%) from 21 different species. In all, 65 cefotaxime-resistant E. coli ESBL/AmpC genes were detected, mainly comprising variants of blaCTX-M and blaCMY-2. Furthermore, PMQR genes [aac(6')-lb-cr, qnrB1, and qnrS1] coincided in seven cefotaxime-resistant E. coli isolates. Overall, replicon typing of the ESBL/AmpC-carrying plasmids demonstrated the predominant presence of IncI1 (n = 31) and variants of IncF (n = 18). Our results indicate a wide dissemination of ESBL and AmpC genes in wild birds from The Netherlands, especially among aquatic-associated species (waterfowl, gulls, and waders). The identified genes and plasmids reflect the genes found predominantly in livestock animals as well as in humans.

Indexed as

beta-Lactam ResistanceAnimalsAnti-Bacterial AgentsBirdsCefotaximeCloacaElectrophoresis, Gel, Pulsed-FieldEscherichia coliEscherichia coli InfectionsMicroarray AnalysisMicrobial Sensitivity TestsMolecular TypingNetherlandsPlasmidsPolymerase Chain ReactionSequence Analysis, DNAAnti-Bacterial AgentsCefotaxime

Identifiers

PMID24038683
PMCPMC3837810
OpenAlexW2127136734

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.